Catalyst Wire Dossier Catalyst Wire Dossier

Dextromethorphan/quinidine

dextromethorphan/quinidine · Avanir Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Dextromethorphan/quinidine, covering 2016-07-14 to 2024-01-05. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington's Disease [Phase 3]

See pricing